Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up to $1.93 billion to develop therapies ...
Jan 29 (Reuters) - Drugmaker Eli Lilly is partnering with Repertoire Immune Medicines in a deal worth up to $1.93 billion to develop therapies for multiple autoimmune diseases, the Massachusetts-based ...
Advanced cancer detection, hormone therapies and microdoses of GLP-1 sound like medical treatments for the rich and chic. One company is taking them to the Super Bowl so that anyone can try them. Hims ...
Bimzelx is a brand-name biologic medication used to treat plaque psoriasis and other conditions by blocking specific immune system proteins that cause inflammation. More common side effects of Bimzelx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results